NEW YORK, Feb. 23, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) and its board of directors concerning the proposed acquisition of the company by MEI Pharma, Inc. (NASDAQ:MEIP). Infinity Pharmaceutical stockholders are expected to own 42% of the combined company. The all-stock transaction is expected to close in mid-2023.
Read more at prnewswire.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Infinity Pharmaceuticals, Inc.
PR Newswire -
Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/AI%20(artificial%20intelligence)/3D%20Graphics%20Concept%20Big%20Data%20Center%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
